Marko Hyvönen

Marko Hyvönen is a Fellow at the University of Cambridge, affiliated with the School of Biological Sciences. His research focuses on understanding cellular communication, signal transmission, and how cells interpret signals at an atomic level. His work examines the impact of communication errors on disease states and explores methods to develop drugs targeting these signalling molecules. Research areas include protein structure, growth factors, chemical biology, drug discovery, and protein engineering. Techniques employed involve protein production, protein crystallography, fragment screening, and biophysical analyses.

Marko Hyvönen is a researcher at the University of Cambridge specializing in TGF-beta signalling, structure-guided drug discovery, fragment-based drug discovery, and protein engineering. His work focuses on understanding the molecular mechanisms of protein interactions and their implications in disease. Hyvönen's research includes structural studies of domains such as PH domains and WW domains, as well as the development of novel methods for protein modification and drug discovery. His publications explore the structural basis of signalling pathways, the design of stapled peptides, and the functional characterization of proteins involved in cellular processes. His contributions span structural biology, biochemistry, and drug discovery, with an emphasis on therapeutic applications.